Source link : https://www.newshealth.biz/health-news/immunotherapy-and-survival-in-nsclc-does-obesity-matter/
TOPLINE: Among patients with overweight or obesity, frontline immunotherapy for advanced non–small cell lung cancer (NSCLC) was not associated with a survival benefit compared with conventional chemotherapy. Overall, however, compared with low body mass index (BMI), overweight or obesity was associated with a lower risk for mortality among patients receiving either therapy. METHODOLOGY: The association […]
Author : News Health
Publish date : 2024-08-12 12:08:52
Copyright for syndicated content belongs to the linked Source.
Categories